Dr. Hengster, Loesch & Kollegen are investment agents focused on long-term return.

Dr. Hengster, Loesch & Kollegen

GalCap Europe specializes in real estate investment management, particularly in Austria and neighboring regions. The firm provides investment and asset management, real estate M&A, and private equity structures. It focuses on institutional investors and offers services tailored to their needs, emphasizing local expertise and efficient decision-making.

GalCap Europe

Invest in Visions is engaged in providing access to impact investments for institutional and private investors, aiming to deliver both financial returns and social impact.

Invest in Visions

SUSI Partners is an independent investment manager that provides institutional investors with access to mid-market private infrastructure opportunities related to the global energy transition.

SUSI Partners

Dr. Hengster, Loesch & Kollegen are investment agents that focus on long term return.

Dr. Hengster, Loesch &amp; Kollegen | 158 followers on LinkedIn. Investment Agents for Long Term Return | Unser Geschäftsmodell ist im Ansatz so einfach wie überzeugend. Wir machen aus drei Parteien zufriedene Partner. Ganz praktisch setzen wir uns mit unseren Institutionellen Investoren zusammen und eruieren, wie sie investieren wollen.

Metric
Company Name	Dr. Hengster, Loesch & Kollegen	GalCap Europe	Invest in Visions	SUSI Partners
Symbol
MSH ID	DE:HENGSTERLOESCH	COM:GALCAP-EUROPE	COM:INVESTINVISIONS	COM:SUSI-PARTNERS
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Real Estate	Financial Services & Finance	Financial Services & Finance
Industry	Investment Management	Investment Management	Investment Management	Investment Management
Country	DE	AT	DE	CH
Stage
Employee Count
Website	hengsterloesch.de	galcap-europe.com	investinvisions.com	susi-partners.com
LinkedIn	hengsterloesch
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic				1.06K
Web Traffic Growth				-0.87
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

HENG

DE:HENGSTERLOESCH

Dr. Hengster, Loesch & Kollegen

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue